Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-27 @ 2:29 AM
Study NCT ID:
NCT07464535
Status:
COMPLETED
Last Update Posted:
2026-03-11
First Post:
2026-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese Subjects
Sponsor:
Tonix Pharmaceuticals, Inc.
Organization: